Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Protara Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for cancer and rare diseases. Its portfolio includes TARA-002, an immunotherapy for bladder cancer and lymphatic malformations, and IV Choline Chloride for patients on parenteral support. The company leverages scientific advancements and strategic collaborations to bring innovative, potentially life-saving treatments to underserved patient populations.
This description was generated via AI from an annual report. Updated about 1 year ago.